Scientific research claims that the lethal and blindingly infected eye drops that were recalled earlier this year, and produced in India at a facility that was not FDA-inspected have bacteria in them
According to The New York Times, scientists are worried that the once-rare, treatment-resistant bacteria detected in the eye drops could spread from person to person and become a persistent issue.
Artificial tears and ointment products made by EzriCare and Delsam Pharma were recalled in January as a result of a P. aeruginosa connection. At least 68 infections, including three fatalities and at least eight cases of blindness, have been brought on by the bacteria. According to the Times, which quoted FDA and CDC lead investigator Maroya Walters, PhD, the eyedrops were brought into the United States from India, and majority of the instances happened after the germs passed from person to person at a long-term care facility in Connecticut. According to Walters, the EzriCare artificial tears product was to blame in incidents that resulted in death or blindness.
The bacteria sticks to water faucets, sink drains, and other wet areas, making it difficult to eradicate, according to infectious disease expert David van Duin, MD, PhD, of the University of North Carolina.
The FDA reported stopping the import of the recalled goods and visiting the Global Pharma Healthcare-owned manufacturing facility in India where they were produced since then. About a dozen issues, including filthy equipment and the lack of safety procedures and tests, were noted by the FDA in a citation to the company dated March 2.